🟢 IDEXX is trading 4.14% up in pre-market with no confirmed catalyst for the rise

IDEXX is trading 4.14% higher at $539.43 before the October 12, 2026 session, with no confirmed new company announcement explaining the pre-market move.

• The CoVetAI acquisition is company-specific background, but IDEXX announced it on September 16, so it does not establish a fresh catalyst.
• Healthcare is stronger in the supplied pre-market context, led by managed-care names; it may offer sector support, but no source directly links it to IDEXX.
• The available evidence does not establish a clear cause.